Arcadia Biosciences, Inc.
RKDA- Exchange
- Nasdaq
- Industry
- Crude Petroleum & Natural Gas
- SEC CIK
- 0001469443
No open-market purchases or sales by Arcadia Biosciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $146.5K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Arcadia Biosciences, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 17 | 18 | +1 |
| Shares | 350.4K | 212.5K | −137.9K (−39.4%) |
| Value | $483.5K | $146.5K | −$337.0K (−69.7%) |
New holders (8)
Institutions that held Arcadia Biosciences, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 88,386 | $60.0K | 0.00% |
| Citadel Advisors LLC | 23,738 | $16.1K | 0.00% |
| Virtu Financial LLC | 21,786 | $15.0K | 0.00% |
| StoneX Group Inc. | 13,682 | $11.3K | 0.00% |
| XTX Topco Ltd | 15,475 | $10.5K | 0.00% |
| Jane Street Group, LLC | 10,245 | $6.96K | 0.00% |
| TD Waterhouse Canada Inc. | 70 | $50 | 0.00% |
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.00% |
Sold out (7)
Institutions that held Arcadia Biosciences, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Armistice Capital, LLC | 159,390 | $220.0K |
| Sabby Management, LLC | 114,554 | $158.1K |
| Susquehanna International Group, LLP | 12,614 | $17.4K |
| Vanguard Fiduciary Trust Co | 4,394 | $6.06K |
| Tower Research Capital LLC (TRC) | 3,940 | $5.44K |
| Assetmark, Inc | 5 | $7 |
| Citigroup Inc | 1 | $1 |